BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16585524)

  • 21. Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.
    Brownell J; Bruckner J; Wagoner J; Thomas E; Loo YM; Gale M; Liang TJ; Polyak SJ
    J Virol; 2014 Feb; 88(3):1582-90. PubMed ID: 24257594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
    Dansako H; Ikeda M; Kato N
    FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus controls interferon production through PKR activation.
    Arnaud N; Dabo S; Maillard P; Budkowska A; Kalliampakou KI; Mavromara P; Garcin D; Hugon J; Gatignol A; Akazawa D; Wakita T; Meurs EF
    PLoS One; 2010 May; 5(5):e10575. PubMed ID: 20485506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
    Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
    J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.
    Lin R; Lacoste J; Nakhaei P; Sun Q; Yang L; Paz S; Wilkinson P; Julkunen I; Vitour D; Meurs E; Hiscott J
    J Virol; 2006 Jun; 80(12):6072-83. PubMed ID: 16731946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1.
    Yeon SH; Song MJ; Kang HR; Lee JY
    Immunology; 2015 Feb; 144(2):312-20. PubMed ID: 25158146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction.
    Oshiumi H; Ikeda M; Matsumoto M; Watanabe A; Takeuchi O; Akira S; Kato N; Shimotohno K; Seya T
    PLoS One; 2010 Dec; 5(12):e14258. PubMed ID: 21170385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
    Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
    PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
    Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
    J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
    Franco S; Clotet B; Martínez MA
    Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
    Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
    J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
    Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
    J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.
    Daffis S; Suthar MS; Szretter KJ; Gale M; Diamond MS
    PLoS Pathog; 2009 Oct; 5(10):e1000607. PubMed ID: 19798431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1.
    Lim YJ; Koo JE; Hong EH; Park ZY; Lim KM; Bae ON; Lee JY
    Cytokine; 2015 Mar; 72(1):63-70. PubMed ID: 25585356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
    Oshiumi H; Sakai K; Matsumoto M; Seya T
    Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
    Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
    Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolysis of MDA5 and IPS-1 is not required for inhibition of the type I IFN response by poliovirus.
    Kotla S; Gustin KE
    Virol J; 2015 Oct; 12():158. PubMed ID: 26437794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.
    Desai MM; Gong B; Chan T; Davey RA; Soong L; Kolokoltsov AA; Sun J
    Gastroenterology; 2011 Aug; 141(2):674-85, 685.e1-6. PubMed ID: 21683701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
    Wang Y; Ye L; Wang X; Li J; Song L; Ho W
    Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection.
    Zhao G; An B; Zhou H; Wang H; Xu Y; Xiang X; Dong Z; An F; Yu D; Wang W; Bao S; Xie Q
    Int J Mol Med; 2012 Dec; 30(6):1498-504. PubMed ID: 22992810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.